Mutations in the TP53 gene show features of somatic hypermutation process with prominent difference between IGHV mutated and unmutated chronic lymphocytic leukemia.

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors

TOM Nikola MALČÍKOVÁ Jitka RADOVÁ Lenka KANTOROVÁ Barbara PARDY Filip PAVLOVÁ Šárka PÁL Karol BIKOS Vasileios TICHÝ Boris DOUBEK Michael BRYCHTOVÁ Yvona PLEVOVÁ Karla MAYER Jiří TRBUŠEK Martin POSPÍŠILOVÁ Šárka

Year of publication 2015
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info